MAP2K1 and colorectal cancer: For example, in the monitoring of advanced colorectal cancer, ctDNA enables the dynamic and repeated assessment of changes in multiple key molecules of the tumor, such as EGFR, ERBB2, PIK3CA, and MAP2K1, among others.